| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |